Cardiology

Myocardial Extracorporeal Shock Wave Therapy Seems to Really Work in Refractory Angina Patients

Slavich M, Ancona F, Margonato A Unità Terapia Intensiva Coronarica, IRCCS San Raffaele Scientific Institute, Milan, Italy Presented during the Acute Cardiovascular Care congress  2015 (17 – 19 October, Vienna)  Introduction: Refractory angina represents a well defined population of patients with angina that are not suitable for further revascularization procedures and complain symptoms on top of medical therapy. Extracorporeal shock wave therapy (ESWT) represents an innovative non invasive tool capable to promote the release of...

read more

Multimodality imaging of myocardial revascularization using cardiac shock wave therapy

G. Zuoziene, D. Leibowitz, J. Celutkiene, G. Burneikaite, L. Ivaskeviciene, G. Kalinauskas, V.V. Maneikiene, D. Palionis, V. Janusauskas, N. Valeviciene, A. Laucevicius International Journal of Cardiology 187 (2015) 229–230 Ischemic heart disease remains a leading cause of morbidity and mortality worldwide. Despite modern therapies, many patients still suffer from refractory angina pectoris (RAP) therefore, alternative non-invasive revascularization methods are under development. One of the methods stimulating angiogenesis is cardiac shock...

read more

Extracorporeal Shockwave Myocardial Revascularization Therapy in Refractory Angina Patients

Slavich Massimo, Ancona Francesco, Margonato Alberto International Journal of Cardiology 2015. 194: p. 93.  Refractory angina represents the real new challenge for clinical cardiologists. Despite all the interventional and medical progress, it is not uncommon to feel disarmed facing highly symptomatic patients already on top of medical therapy, not eligible for further revascularization. The increased prevalence of the disease, also because of the raised life expectancy and comorbidities in general which might constrain the indication to...

read more

Cardiac shock wave therapy and myocardial perfusion in severe coronary artery disease

Kaller, M., et al., Clin Res Cardiol, 2015 Background Ultrasound guided cardiac shock wave therapy (CSWT) is a noninvasive therapeutic option in the treatment of chronic-refractory angina. Clinical trials have shown that CSWT reduces angina symptoms, improves regional systolic function, LV ejection fraction, myocardial perfusion and quality of life parameters. Absolute measurements of myocardial perfusion before and after CSWT have not been performed so far. Read...

read more

The Beneficial Effect of Extracorporeal Shockwave Myocardial Revascularization in Patients With Refractory Angina

Alunni G, et al, The beneficial effect of extracorporeal shockwave myocardial revascularization in patients with refractory angina, Cardiovasc Revasc Med (2014) Objectives The incidence of patients with refractory angina (RA) is increasing. Medical therapy for RA is limited and prognosis is poor. Experimental data suggest that the use of Extracorporeal shockwave myocardial revascularization (ESMR) may contribute to angiogenesis and improve symptoms of angina in patients with RA. Purpose of our study is to determine the efficacy of cardiac...

read more

Echo-guided extracorporeal shock wave therapy for refractory angina improves regional myocardial blood flow and longitudinal

Lother Faber, Oliver Lindner*, Christian Prinz, Nicola Bogunovic, Detlef Hering, Wolfgang Burchert*, Dieter Horstkotte Departments of Cardiology and *Radiology, Nuclear Medicine and Molecular Imaging,Heart and Diabetes Center North Rhine-Westphalia, Ruhr University of Bochum, Bad Oeynhausen, Germany Introduction and Background At high energy levels, electrohydraulical shock waves (SW) can be used to mechanically desintegrate calculi in the urinary and biliary tract (nephro- and cholelithotripsy). Low intensity SW therapy (SWT) has been shown...

read more

Myocardial shockwave therapy improves global and regional left ventricular function in patients with stable ischemic heart disease regardless of baseline contractility

G. Burneikaite(1), G. Zuoziene(2), J. Celutkiene(1), I. Butkuviene2, A. Laucevicius(1) (1)-Vilnius University, Faculty of Medicine, Vilnius, Lithuania; (2)- Vilnius University, Center of Cardiology and Angiology, Vilnius, Lithuania   Purpose: New myocardial revascularization method– myocardial shockwave therapy (MSWT)- stimulates angiogenesis in experimental studies. We hypothesize, that MSWT improves myocardial global and regional contraction in patients with stable ischemic heart disease, regardless of baseline...

read more

Extracorporeal Shockwave Myocardial Revascularization Improves Anginal Symptoms, Exercise Tolerance and Ischemic Burden in Patients with Refractory Angina Pectoris: A Multicenter Study

Megha Prasad; Andrew Cassar; Wan Azman Wan Ahmad; Renan Sukmawan; Edward-Bengie L. Magsombol; Yuri Vinshtok; Muhammad D. Ismail; Ahmad Syadi; Mahmood Zuhdi; Sue Ann Locnen; Maria Palamine; Rodney Jimenez; Homobono Calleja; Amir Lerman J Am Coll Cardiol. 2014;63(12_S):. doi:10.1016/S0735-1097(14)61537-0 Background:Medically refractory angina is significant health concern despite advances in revascularization techniques and emerging medical therapies. Extracorporeal Shockwave Myocardial Revascularization (ESMR) may be a safe and efficacious...

read more

Safety and Efficacy of Extracorporeal Shock Wave Myocardial Revascularization Therapy for Refractory Angina Pectoris

Andrew Cassar, MD,MRCP; Megha Prasad, MD; Martin Rodriguez-Porcel,MD, FAHA; Guy S. Reeder, MD, FACC; Darshak Karia, MD; Anthony N. DeMaria, MD, MACC; and Amir Lerman, MD, FACC Mayo Clinic Proceedings, Volume 89, Issue 3, Pages 346–354, March 2014 Objective: To assess the safety and efficacy of extracorporeal shockwave myocardial revascularization (ESMR) therapy in treating patients with refractory angina pectoris. Patients and Methods: A single-arm multicenter prospective trial to assess safety and efficacy of the ESMR therapy in patients...

read more

Noninvasive Therapy for the Management of Patients With Advanced Coronary Artery Disease

By Kazmi W.H., Rasheed S.Z., Ahmed S., Saadat M., Altaf S., Samad A. (Coronary Artery Disease Journal, December 2012, Volume 23, Issue 8, P. 549-554) OBJECTIVES: To determine the efficacy of cardiac shock wave therapy (CSWT) in the management of patients with end-stage coronary artery disease (CAD). INTRODUCTION: Patients with end-stage CAD have symptoms such as recurrent angina, breathlessness, and other debilitating conditions. End-stage CAD patients are usually those who have angina pectoris following a coronary artery bypass surgery or a...

read more